2[2]Bonsib, S. Glomerular basement membrane discontinuities: Scanning electron microscopic study of acellular glomeruli. Am J Pathol,1985,119:357.
3[3]Morel Maroger Striker L, Killen PD, Chi E, et al. The composition of glomerulosclerosis, crescentic glomerulonephritis, and membranoproliferative glomerulonephritis. Lab Invest,1984,51(2):181.
4[4]Thomson NM, Moran J, Simpson IJ, et al. Defibrination with ancrod in nephrotoxic nephritis in rabbits. Kidney Int,1976,10:343.
5[5]Neale TJ, Tipping PG, Carson SD,et al.Participation of cell-mediated immunity in deposition of fibrin in glomerulonephritis. Lancet,1988,2:421.
6[6]Tipping PG, Erlich JH, Apostolopoulos J, et al. Glomerular tissue factor expression in crescentic glomerulonephritis. Correlations between antigen, activity and mRNA. Am J Pathol,1995,147:1736.
7[7]Erlich JH, Apostolopoulos J, Wun TC, et al. Renal expression of tissue factor pathway inhibitor and evidence for a role in crescentic glomerulonephritis in rabbits. J Clin Invest,1996,98:325.
8[8]Cunningham MA, Ono T, Hewitson TD, et al. Tissue factor pathway inhibitor expression in human crescentic glomerulonephritis. Kidney Int,1999,55:1311.
9[9]Kitching AR, Holdsworth SR, Ploplis VA, et al. Plasminogen and plasminogen activators protect against renal injury in crescentic glomerulonephritis. J Exp Med,1997,185:1.
10[10]Tipping PG, Holdsworth SR. The participation of macrophages, glomerular procoagulant activity and factor VIII in glomerular fibrin deposition: Studies in anti-glomerular basement membrane antibody induced glomerulonephritis in rabbits. Am J Pathol,1986,124:10.
